ALPHA LIPOIC ACID INFUSIONS
Health Associates Medical Group of Sacramento, California has been successfully & safely administering Intravenous Alpha-Lipoic Acid treatments for many years.
Lipoic Acid is also known as Alpha-Lipoic Acidor ALA, and Thioctic Acid. Alpha-Lipoic Acid is a powerful free radical scavenger and a potent antioxidant. Unlike many other anti-oxidants, Alpha-Lipoic Acid is both lipophilic & hydrophilic (fat-soluble and water-soluble) and evidence suggests that it may help to regenerate other well-known antioxidants such as Vitamin C, Vitamin E and also raise intracellular levels of Glutathione.
In addition to its antioxidant and free radical scavenging effects, Alpha-Lipoic Acid has demonstrated neuroprotective, cytoprotective, antihyperglycemic, anti-inflammatory and anti-viral activities.
What does Alpha-Lipoic Acid do?
According to experts in the field, Alpha-Lipoic Acid is one of the best selling drugs in Europe and has been widely used and studied abroad for diabetic peripheral neuropathies and for various liver issues such as Hepatitis C.
Why intravenous administration?
Naturally, our body has very little free circulating Alpha-Lipoic Acid so supplementation can be an attractive alternative and /or concurrent adjunct to conventional therapy in the treatment of Diabetic Neuropathy and liver diseases. Studies have shown that intravenous infusion of alpha-lipoic acid were safe and effective in reducing symptoms of diabetic peripheral neuropathy and these results were not achieved with oral supplementation.
A 1997 study by D Ziegler: “Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy” concluded that intravenous infusion of alpha-lipoic acid over 3 weeks is safe and effective in reducing symptoms of diabetic peripheral neuropathy. https://www.ncbi.nlm.nih.gov/pubmed/9285502
The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. https://www.ncbi.nlm.nih.gov/pubmed/12610036
A 1995 abstract by L Packer - Alpha-Lipoic acid as a biological antioxidant. - NCBI - NIH https://www.ncbi.nlm.nih.gov/pubmed/7649494
1999 by BM Berkson - A conservative triple antioxidant approach to the treatment of hepatitis C.